EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience

PURPOSE: Monitoring mutation status in circulating free DNA (cfDNA) during target therapy could hold significant clinical importance in non-small cell lung cancer (NSCLC). Our aim is to establish if EGFR mutational status change on cfDNA has predictive value that can impact clinical management of NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ianza, Anna, Di Chicco, A., Biagi, C., Giudici, F., Dicorato, A., Guglielmi, A., Variola, F., Tomasi, S., Roviello, G., Generali, D., Zanconati, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236477/
https://www.ncbi.nlm.nih.gov/pubmed/34003366
http://dx.doi.org/10.1007/s00432-021-03658-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236477/
https://www.ncbi.nlm.nih.gov/pubmed/34003366
http://dx.doi.org/10.1007/s00432-021-03658-8

Ejemplares similares